Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered. Based on new findings in ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests. Prostate cancer has distinct genetic properties in ...

More than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the disease remain unexplored for the majority of patients around the world. In the ...

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered. Based on new findings in ...

Researchers shed light on cutting-edge advances of AI in diagnosis, treatment, patient prognosis prediction, and molecular subtyping of PCa. Cancer is a significant global health issue affecting ...

Presented in collaboration with the National Cancer Centre Singapore, this study marks the first validation of the ArteraAI Prostate Test in an Asian prostate cancer population. The test was shown to ...

Real-world landscape of PTEN protein expression and its relationships with HER2 and PSMA in Chinese hormone-sensitive prostate cancer. PSA response among pts with mHSPC after APA plus ADT treatment.

Colina 111 PET results in a nonmetastatic castration-resistant cancer (nmCRPC) in population that is negative by conventional imaging: True incidence from real-world evidence data. This is an ASCO ...

"Prostate cancer is a worldwide problem. It is the most common cancer in men, with clear racial disparities,” said researcher Hui Li, PhD, of the University of Virginia School of Medicine’s Department ...